Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation.

Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation. Acta Radiol. 2020 Mar 26;:284185120909964 Authors: Tegel BR, Huber S, Savic LJ, Lin M, Gebauer B, Pollak J, Chapiro J PMID: 32216452 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32216452?dopt=Abstract

Source: Acta Radiologica - March 25, 2020 Category: Radiology Authors: Tegel BR, Huber S, Savic LJ, Lin M, Gebauer B, Pollak J, Chapiro J Tags: Acta Radiol Source Type: research

More News: Cancer & Oncology | Carcinoma | Kidney Cancer | Radiology | Renal Cell Carcinoma